Mazen Noureddin MD MHSc
individual
About
Mazen Noureddin is a hepatologist and clinical researcher focused on steatotic liver disease, cirrhosis, biomarkers, and non-invasive diagnostics. He was the founding director of the Fatty Liver Program at Cedars-Sinai, later moved to Houston, and is now publicly described as founder of the Houston Research Institute and a scientific leader at Pinnacle Clinical Research. He also serves in advisory roles for liver-focused biotech and diagnostics companies including HepaTx and MetaDeq.
Areas of interest
hepatologyMASLDMASHNAFLDNASHcirrhosisliver diseasebiomarkersnon-invasive diagnosticsclinical trialstranslational medicinecell therapy